Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, ESG

Meru Health's latest study reveals significant impact in suicide prevention


SAN MATEO, Calif., Oct. 9, 2023 /PRNewswire/ -- Meru Health, a technology-enabled digital mental health provider with a novel mind-body approach to mental healthcare, published a peer-reviewed study today in Archives of Suicide Research that reveals an estimated 30% reduction in suicide attempts and death by suicide as well as significant reductions in suicidal ideation.

Meru Health's latest study reveals significant impact in suicide prevention.  

This study adds to Meru Health's evidence base documenting significant reductions in depression and anxiety symptoms. "I'm excited and proud of this peer-reviewed publication showing that Meru Health's treatment intervention helps prevent suicide and suicidal ideation. Meru Health has published over 12 studies in the scientific literature showing its real-world effectiveness, and now we have evidence the program also prevents suicide," said Kristian Ranta, founder and CEO of Meru Health. For Ranta, the topic is personal: "I lost my brother Peter to suicide. This was my reason for founding Meru Health."

Key findings in the published study include:

The results are based on a study of 778 participants who enrolled in the program from January 1 to December 30, 2020. All measures examined in this study were collected in the Meru Health app at baseline before the start of the program, biweekly during the program including at the end of treatment, and via email 3 and 6 months after treatment. The inclusion criteria of the Meru Health program is having at least mild levels of depression, anxiety, or burnout; and not having an active substance use disorder, severe active suicidal ideation with a plan, severe active self-harm, or a history of psychosis or mania.

This study shows that therapist-supported digital interventions like Meru Health can help with addressing the mental health crisis in the United States.

About Meru Health

Meru Health brings you unlimited access to a therapist and powerful daily practices to improve your mental health, nutrition, breath, sleep, and more to achieve superior results compared to traditional cognitive behavioral therapy or antidepressants treatments. Meru Health partners with major health insurance providers like Cigna and Aetna as well as employer groups. For more information, visit www.meruhealth.com

Note: The study discussed here does not negate the importance of urgent care for those with active suicidal ideations. If you or someone you know is actively struggling with mental health issues or suicidal thoughts and actions, text or call the suicide and crisis lifeline at 988.

Media contact: [email protected]

SOURCE Meru Health


These press releases may also interest you

at 10:30
Flourishing Foundations Recovery has launched a new outpatient detox center in San Antonio, TX, aiming to help individuals tackle drug and alcohol addiction without pausing their daily lives. The new substance abuse treatment center ensures easy...

at 08:30
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: